Miltenyi Biotec

Lino Biotech AG, based in Zurich, Switzerland, specializes in developing a unique biosensor platform called Focal Molography, which allows for direct imaging of biomolecular interactions in living cells and biological samples. This innovative technology, protected by broad patents, facilitates label-free detection assays, effectively eliminating signal disturbances caused by temperature fluctuations or non-specific binding. Founded in March 2020, Lino Biotech aims to enhance the quality control processes for cell therapy manufacturers, making these therapies more cost-effective and accessible to a wider patient population. By providing new methods for measuring molecular interactions, the company supports the production and development of cell therapies, ultimately contributing to advancements in biomedicine.

Sensovation AG engages designs, develops, manufactures, and distributes camera based sensors and electro optical measurement systems for biotechnology, medical technology, and diagnostics applications. It offers cameras, such as SamBa Ci that is used for the inspection of solar cells; coolSamBa HR-830 that is used for the electroluminescence inspection of modules in photovoltaic industries.

Lentigen Corporation, a biotechnology company, engages in the development and commercialization of gene delivery technologies for human disease. It provides lentiviral vector technology for a range of therapeutic, vaccine, and research applications in biotechnology and medicine. The company offers LG690, a cell therapy for treatment of graft vs hot diseases; LG768, a cancer vaccine for the treatment of leukemia; stem cell therapy to prevent and treat medical disorders; LG631, a treatment that makes chemotheraphy for brain cancer less toxic; LG889, a steam cell therapy for hemophilia; LG611, an exact strain matched influenza vaccine for pandemic flu; LG811, an exact strain matched influenza vaccine for seasonal flu; LG747, a biosimilar erytho poieitin; and LG888, a novel factor VIII protein therapy for Hemophilia A. Lentigen Corporation was founded in 2004 and is headquartered in Gaithersburg, Maryland.

OWL Biomedical, Inc. is a company based in Santa Barbara, California, that specializes in microchip-based disposable cell sorting technology. This innovative technology is designed for various applications, including cell purification, cancer diagnostics, and stem cell research. It plays a critical role in adoptive immunotherapy for cancer treatment and stem cell therapies in regenerative medicine. Additionally, OWL Biomedical's technology is utilized in the cosmetic and aesthetic markets for stem cell sorting. Founded in 2010 and formerly known as J2D BioMedical, the company has been operating as a subsidiary of Miltenyi Biotec GmbH since 2013.

Eligix, Inc., a biomedical company, engages in the research and development of cellular therapies. The therapies improve human immune response to cancers, autoimmune disorders, and solid organ transplants; and reduce the risk of infection and hypersensitivity reactions in blood transfusions.